By contrast, in hepatocellular carcinoma (HCC), the Gal-9/TIM-3 interaction is necessary to enhance exhausted T cells and to render inefficient anti-cancer immune response [91,106]. The gene discussed is HAVCR2; the disease is hepatocellular carcinoma.